Business

Machaon M. K. Bonafede, PhD, MPH; Donna McMorrow, BS; Clare Proudfoot, PhD; Shraddha Shinde, MS, MBA; Andreas Kuznik, PhD; Chieh-I Chen, MPH
Kathleen F. Villa, MS; Nancy L. Reaven, MA; Susan E. Funk, MBA; Karen McGaughey, PhD; Jed Black, MD
Accurate Diagnosis of Chronic Diseases Can Reduce Costs and Medical Resource Utilization
James T. Kenney, RPh, MBA
Jesse Cambon, MEng; Tristan Cordier, MS; Elizabeth L. Munnich, PhD, MPP; Andrew Renda, MD; Bobby Kapur, MD, MPH; Shkelzen Hoxhaj, MD, MPH, MBA; Meredith Williams, MD, MBA
Opportunities to Improve Urgent and Emergent Care Utilization
Cody Olsen, PharmD, BCPS
Raghu Durvasula, MD, MHA; Janet Kelly, PharmD; Anneliese Schleyer, MD, MHA; Bradley D. Anawalt, MD; Shabir Somani, MS, MBA, RPh, FASHP; Timothy H. Dellit, MD
Pharmacy & Therapeutics Committees’ New Challenge: Stewardship for Specialty Drugs
Byron C. Scott, MD, MBA
Eric M. Maiese, MHS, PhD; Kristin A. Evans, PhD; Bong-Chul Chu, PhD; Debra E. Irwin, MSPH, PhD
Improved Clinical Outcomes with Newer Multiple Myeloma Therapies Associated with Increased Resource Utilization and Financial Burden
Matthew Mitchell, PharmD, MBA, FAMCP
Yuexin Tang, PhD; Xingyue Huang, PhD; Jinan Liu, PhD; R. Ravi Shankar MD; Michael L. Ganz, PhD; Swapnil Rajpathak, MD, DrPH
Impact of Step Therapy Restrictions in Diabetes Care
Quang T. Nguyen, DO, FACP, FACE, FTOS
Rajeev Ayyagari, PhD; Maureen Neary, PhD, MS; Shang Li, MS; Ariel Rokito, BS; Hongbo Yang, PhD; Jipan Xie, MD, PhD; Al B. Benson III, MD, FACP, FASCO
Michael S. Broder, MD, MSHS; Tiffany P. Quock, PhD, MS; Eunice Chang, PhD; Sheila R. Reddy, PhD, RPh; Rajni Agarwal-Hashmi, MD; Sally Arai, MD; Kathleen F. Villa, MS
More Data Analysis Is Needed to Improve Outcomes, Lower Costs, and Maximize Appropriate Resource Use
James T. Kenney, RPh, MBA
Burton S. Brodsky, MD; Gary M. Owens, MD; Dennis J. Scotti, PhD, MBA; Keith A. Needham, BS; Christina L. Cool, MPH
Economic Impact of Using Tests to Guide the Treatment of Patients with Ovarian Cancer
F. Randy Vogenberg, PhD, RPh
Katherine M. Prioli, BS; Laura T. Pizzi, PharmD, MPH; Kathryn M. Kash, PhD; Andrew B. Newberg, MD; Anna Marie Morlino, PharmD; Michael J. Matthews, BS; Daniel A. Monti, MD
Creative Therapeutic Activities and Support Groups Benefit All Those Involved in Cancer Care
Linda Bily, MA, CSA, OPN-CG
Page 4 of 15
Results 31 - 40 of 145
Copyright © Engage Healthcare Communications, LLC. All rights reserved.